Literature DB >> 4058305

Primary non-Hodgkin's lymphoma of the brain. A review.

R Woodman, K Shin, G Pineo.   

Abstract

We have reported 14 primary non-Hodgkin's lymphomas of the brain seen in Calgary and Edmonton, Alberta, between 1975 and 1983. Eleven patients had histiocytic lymphoma while the remaining 3 were lymphocytic. The clinical presentations were extremely variable, with increased intracranial pressure (60%) and focal neurological deficits (60%) being most common. The most frequent appearance on computed tomographic scan was a hyperdense lesion of the cerebrum (44%); four cases had multifocal lesions. All patients had subtotal resection of the tumor. Two patients had surgery only and their mean survival was 3.5 months. Ten patients received whole brain irradiation, with 2 patients receiving a boost to the primary tumor site as well. The mean survival was 24.7 months. Two patients received chemotherapy in addition to radiotherapy and their mean survival was 20.0 months. Three of the 14 patients have had an inordinately long disease-free survival of 64, 75, and 80 months from the time of diagnosis.

Entities:  

Mesh:

Year:  1985        PMID: 4058305     DOI: 10.1097/00005792-198511000-00006

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  15 in total

1.  Brain lesion and AIDS.

Authors:  J T Gage; E A Vance; P G Hildenbrand; T Mattison
Journal:  Proc (Bayl Univ Med Cent)       Date:  2000-10

2.  Primary B-cell lymphoma of the CNS in an infant.

Authors:  J C Egelhoff; E C Beatty
Journal:  Pediatr Radiol       Date:  1989

3.  Intracranial primary dural diffuse large B-cell lymphoma successfully treated with chemotherapy.

Authors:  Angelo Borsarelli Carvalho Brito; Fabiano Reis; Cármino Antonio de Souza; José Vassallo; Carmen Silvia Passos Lima
Journal:  Int J Clin Exp Med       Date:  2014-02-15

Review 4.  Primary cranial vault lymphoma mimicking meningioma.

Authors:  A Isla; F Alvarez; M Gutiérrez; C Gamallo; M García-Blázquez; A Vega
Journal:  Neuroradiology       Date:  1996-04       Impact factor: 2.804

5.  PROMACE-MOPP and intrathecal chemotherapy for CNS lymphomas.

Authors:  S Dent; L Eapen; A Girard; H Hugenholtz; V DaSilva; D J Stewart
Journal:  J Neurooncol       Date:  1996-04       Impact factor: 4.130

6.  An immunohistochemical analysis of T cells in primary B cell malignant lymphoma of the brain.

Authors:  A Nishiyama; T Saito; S Abe; T Kumanishi
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

7.  Primary central nervous system lymphoma in Japan--a retrospective, co-operative study by CNS-Lymphoma Study Group in Japan.

Authors:  T Hayakawa; K Takakura; H Abe; T Yoshimoto; R Tanaka; K Sugita; H Kikuchi; T Uozumi; T Hori; H Fukui
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

Review 8.  Primary central nervous system lymphomas--an update.

Authors:  K A Jellinger; W Paulus
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

9.  Solitary primary CNS lymphoma: long term survival following total resection.

Authors:  W Sonstein; K Tabaddor; J F Llena
Journal:  Med Oncol       Date:  1998-04       Impact factor: 3.064

10.  Chemotherapy as first treatment for primary malignant non-Hodgkin's lymphoma of the central nervous system preliminary data.

Authors:  A Boiardi; A Silvani; S Valentini; A Salmaggi; A Allegranza; G Broggi
Journal:  J Neurol       Date:  1993-12       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.